Lifting the Mist on Gastric Stem Cells

Slides:



Advertisements
Similar presentations
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Advertisements

Distinct Self-Renewal and Differentiation Phases in the Niche of Infrequently Dividing Hair Follicle Stem Cells Ying V. Zhang, Janice Cheong, Nichita Ciapurin,
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Distribution of Human Embryonic Stem Cell Lines: Who, When, and Where Jennifer B. McCormick, Jason Owen-Smith, Christopher Thomas Scott Cell Stem Cell.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells David J. Wong, Helen Liu, Todd W. Ridky, David Cassarino, Eran Segal, Howard.
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Fate Restriction and Multipotency in Retinal Stem Cells Lázaro Centanin, Burkhard Hoeckendorf, Joachim Wittbrodt Cell Stem Cell Volume 9, Issue 6, Pages.
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.
Quantitative Single-Cell Approaches to Stem Cell Research Martin Etzrodt, Max Endele, Timm Schroeder Cell Stem Cell Volume 15, Issue 5, Pages (November.
Yoku Hayakawa, James G. Fox, Timothy C. Wang 
Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey 
Chemotherapy and Cancer Stem Cells
T-ALL: Home Is where the CXCL12 Is
Cancer: Inappropriate Expression of Stem Cell Programs?
Back to 2D Culture for Ground State of Intestinal Stem Cells
Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey 
Volume 14, Issue 6, Pages (June 2014)
Volume 1, Issue 1, Pages (June 2007)
Cell Cycle Rules Pluripotency
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
Volume 16, Issue 6, Pages (June 2015)
Expanding the Lauren Classification: A New Gastric Cancer Subtype?
Gerry P. Crossan, Juan I. Garaycoechea, Ketan J. Patel  Cell Stem Cell 
One Niche to Rule Both Maintenance and Loss of Stemness in HSCs
Blocking HIF1α Activity Eliminates Hematological Cancer Stem Cells
Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs
Anselme Perrier, Marc Peschanski  Cell Stem Cell 
MSCs, Macrophages, and Cancer: A Dangerous Ménage-à-Trois
MDS Is a Stem Cell Disorder After All
Neural Circuits Serve as Periscopes for NSCs
Justin Brumbaugh, Konrad Hochedlinger  Cell Stem Cell 
Regulating Cancer Stem Cells the miR Way
A New Image of the Hematopoietic Stem Cell Vascular Niche
Stem Cell Therapies in Clinical Trials: Progress and Challenges
Cancer Cell of Origin: Spotlight on Luminal Progenitors
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
TRRAP and the Maintenance of Stemness in Gliomas
Gliomas “Dope Up” for Growth
Blocking HIF1α Activity Eliminates Hematological Cancer Stem Cells
Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs
Putting Two Heads Together to Build a Better Brain
Tregs Expand the Skin Stem Cell Niche
MicroRNAs and Parallel Stem Cell Lives
Not So Lonely at the Top for Cancer Stem Cells
Volume 18, Issue 2, Pages (February 2016)
KLF4 Initiates Acinar Cell Reprogramming and Is Essential for the Early Stages of Pancreatic Carcinogenesis  Ravikanth Maddipati, Jonathan P. Katz  Cancer.
Rushika M. Perera, Nabeel Bardeesy  Cancer Cell 
Puma: Mauling the Intestinal Crypt
Common TLR5 Mutations Control Cancer Progression
Targeting β-catenin in CML: Leukemia Stem Cells Beware!
Meddling with METTLs in Normal and Leukemia Stem Cells
Powering Reprogramming with Vitamin C
Hit 'Em Where They Live: Targeting the Cancer Stem Cell Niche
NO Signals from the Cancer Stem Cell Niche
Stressing Out PanIN: NRF2 Pushes over the Edge
Selfish Stem Cells Compete with Each Other
Chapter 29 - Stem Cells and Generation of New Cells in the
Using Notches to Track Mammary Epithelial Cell Homeostasis
Searching for leukemia stem cells—Not yet the end of the road?
c-Raf in KRas Mutant Cancers: A Moving Target
Special Stem Cells for Bone
Devyn M. Smith, Emily J. Culme-Seymour, Chris Mason  Cell Stem Cell 
Notching Up MYC Gives a LIC
Knocking the Wnt out of the Sails of Leukemia Stem Cell Development
Justin Brumbaugh, Konrad Hochedlinger  Cell Stem Cell 
Presentation transcript:

Lifting the Mist on Gastric Stem Cells Julia Varga, Florian R. Greten  Cell Stem Cell  Volume 18, Issue 1, Pages 7-9 (January 2016) DOI: 10.1016/j.stem.2015.12.008 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Mist1+ Isthmus Cells Serve as Both Normal and Cancer Stem Cells and Are Supported by Wnt5a-Producing Cxcr4+ ILCs (A) Mist1+ isthmus cells reside in a specialized niche composed of Cxcl12+ endothelium and Cxcr4+ ILCs, which produce Wnt5a. Mist1+ stem cells are capable of generating all differentiated cell types in the corpus gland. (B) Mist1+ cells serve as cells-of-origin both for intestinal-type and diffuse-type gastric cancer. Concomitant Kras mutation and loss of Apc or Notch activation triggers intestinal metaplasia and intestinal-like gastric cancer. On the other hand loss of E-cadherin together with inflammation results in the formation of premalignant cells (signet ring cells) that progress into diffuse-type gastric cancer. Cxcr4+ ILCs are expanded in the cancer stem cell niche resulting in elevated levels of Wnt5a when compared to the normal stem cell niche. (C) Targeting the stem cell niche by a small-molecule Cxcr4 antagonist or by depleting ILCs provides a promising new therapeutic approach in diffuse-type gastric cancer. Cell Stem Cell 2016 18, 7-9DOI: (10.1016/j.stem.2015.12.008) Copyright © 2016 Elsevier Inc. Terms and Conditions